Cargando…
Novel mechanism for OSM-promoted extracellular matrix remodeling in breast cancer: LOXL2 upregulation and subsequent ECM alignment
BACKGROUND: Invasive ductal carcinoma (IDC) is a serious problem for patients as it metastasizes, decreasing 5-year patient survival from > 95 to ~ 27%. The breast tumor microenvironment (TME) is often saturated with proinflammatory cytokines, such as oncostatin M (OSM), which promote epithelial-...
Autores principales: | Dinca, Simion C., Greiner, Daniel, Weidenfeld, Keren, Bond, Laura, Barkan, Dalit, Jorcyk, Cheryl L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8132418/ https://www.ncbi.nlm.nih.gov/pubmed/34011405 http://dx.doi.org/10.1186/s13058-021-01430-x |
Ejemplares similares
-
Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth
por: Weidenfeld, Keren, et al.
Publicado: (2016) -
EMT and Stemness in Tumor Dormancy and Outgrowth: Are They Intertwined Processes?
por: Weidenfeld, Keren, et al.
Publicado: (2018) -
HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β
por: Tawara, Ken, et al.
Publicado: (2019) -
The clinical relevance of OSM in inflammatory diseases: a comprehensive review
por: Wolf, Cody L., et al.
Publicado: (2023) -
OSM potentiates preintravasation events, increases CTC counts, and promotes breast cancer metastasis to the lung
por: Tawara, Ken, et al.
Publicado: (2018)